74th                                              

June 29

 
Welcome
Fred Saad
VIEW  
Welcome
Naeem Bhojani and Wassim Kassouf
VIEW  
Welcome
Stéphane Bolduc
VIEW  
 

State-of-the-Art Lecture 1

 
A doctor's guide to starting a startup
Brett Belchetz
VIEW PDF
 

State-of-the-Art Lecture 2

 
AI in healthcare and surgery
Frank Rudzicz
VIEW  
 

CUOG Lecture

 
Reducing errors in science
Laurence Klotz
VIEW PDF
 

Allied Urology Association Addresses

 
AUA
John Lynch
VIEW PDF
 

State-of-the-Art Lecture 4

 
Reducing radiation risk for you and your patient
Mitchell Humphreys
VIEW PDF
 

Educational Forum 2

 
How to treat the stones you don't want to treat?
Michael Kogon, Mitchell Humphreys and Trevor Schuler
VIEW PDF
 

Podium Session 1: Endourology, BPH, Robotics

 
WATER II: AquablatTherapy for Benign Prostatic Hyperplasia (80-150cc) 12 month safety and efficacy results
Naeem Bhojani
VIEW PDF
Demonstration of an effective ultra- low dose CT protocol with lower radiation dose than abdominal x-ray
Kymora Scotland
VIEW PDF
Predicting ureteric stone expulsion with patient reported outcomes: a prospective observational study
Ryan McLarty
VIEW PDF
“Stone-free,” now what? A retrospective review of patients following stone free status
Mark Assmus
VIEW PDF
Surgical Performance as a Predictor of Functional and Oncological Outcomes in Robotic Prostatectomy
Mitchell Goldenberg
VIEW PDF
A population-based comparison of healthcare utilization and retreatment after electrode and laser transurethral prostatectomies
Blayne Welk
VIEW PDF
 

Educational Forum – Clearing the Path: Untangling advanced prostate cancer management

 
Untangling advanced prostate cancer management
Kim Chi
VIEW PDF
Untangling advanced prostate cancer management
Scott North
VIEW PDF
Untangling advanced prostate cancer management
Fred Saad
VIEW  
 

State-of-the-Art Lecture 5

 
Gender confirmation surgery: What every urologist needs to know
Richard Santucci
VIEW PDF
 

CRPC guidelines

 
CRPC guidelines
Fred Saad
VIEW PDF
 

June 30

 
 
Practice changing studies in GU oncology 2018/2019
Bobby Shayegan
VIEW PDF
 

State-of-the-Art Lecture 6

 
Treating the primary in metastatic prostate cancer: Lessons from the STAMPEDE trial
Nicholas James
VIEW PDF
 

Educational Forum 3

 
Case based approach in the management of low volume intermediate risk prostate cancer
Joseph Chin, Éric Vigneault and Luke Lavallee
VIEW PDF
 

State-of-the-Art Lecture 7

 
Balancing the risks and benefits of testosterone replacement
Ronald Lewis
VIEW PDF
 

Urethral stricture guidelines

 
Urethral stricture guidelines
Keith F. Rourke
VIEW PDF
 

Podium Session 2: Mixed Non-oncology

 
Opioid prescription to patients after low acuity urologic surgery is a risk factor for long-term opioid use
Jeffrey Campbell
VIEW PDF
Efficacy and safety of mirabegron vs. placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia (PLUS)
Sender Herschorn
VIEW PDF
Randomized blinded placebo controlled trial of continuous antibiotic prophylaxis for febrile UTI prevention in infants with prenatal hydronephrosis: the alpha study
Luis Braga
VIEW PDF
Are renal bladder ultrasounds necessary for routine follow-ups of vesicoureteral reflux patients after continuous antibiotic prophylaxis discontinuation?
Catherine Anne (Kate) Lovatt
VIEW PDF
Comprehensive Prospective Assessment of Patient Reported Outcomes after Urethroplasty
Jordan Bekkema
VIEW PDF
Implementing and evaluating the efficacy of an Acute Care Urology model of care in a large community hospital
Abirami Kirubarajan
VIEW PDF
 

Podium Session 3: Prostate Cancer

 
Phase 3 study of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): the ARCHES trial
Cristiano Ferrario
VIEW PDF
A novel predictor of clinical progression in patients on active surveillance for prostate cancer
Guan Hee Tan
VIEW PDF
Comparison of bone scintigraphy and 18FDG-PET/CT to stage high-grade prostate cancers shows 18FDG-PET/CT has a better accuracy to detect bone metastasis.
Samuel Otis-Chapados
VIEW PDF
Widespread use of multiparametric MRI in an active surveillance cohort results in earlier identification and treatment of clinically significant prostate cancer
Alice Yu
VIEW PDF
Comparison of Salvage Prostatectomy versus Salvage Ablative Therapy for Biopsy Proven Radiorecurrent Localized Prostate Cancer.
Victor McPherson
VIEW PDF
Impact of bone-targeted therapies in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer on enzalutamide: a post hoc analysis of PREVAIL
Fred Saad
VIEW PDF
 

State-of-the-Art Lecture 8

 
Navigating female stress incontinence in the era of mesh
Kathleen Kobashi
VIEW PDF  
   

Educational Forum 4

 
Navigating female stress incontinence in the era of mesh - Common and complex cases in stress urinary incontinence
Kathleen Kobashi (PDF), Gary Gray (PDF) and Matthew Andrews (PDF)
VIEW  
 

CUASF Lecture

 
Management of invasive bladder cancer: The case for integration, regionalization and oncology subspecialization n
Armen Aprikian
VIEW PDF
 

State-of-the-Art Lecture 9

 
Medical quackery
Joe Schwarcz
VIEW PDF
 

July 1

 
Practice changing studies in benign urology 2018/2019
Shubha De
VIEW PDF
 

Podium Session 4: Mixed Oncology

 
TLD-1433 Photodynamic Therapy for BCG-Unresponsive NMIBC – A Phase Ib Clinical Study
Girish Kulkarni
VIEW PDF
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Anna Black
VIEW PDF
Statin use and mortality in bladder cancer patients undergoing radical cystectomy in Quebec province, 2000-2014
Armen Aprikian
VIEW PDF
IDENTIFY: The Investigation and DEtection of urological Neoplasia in paTIents reFerred with suspected urinarY tract cancer: A multicentre analysis
Mark Assmus
VIEW PDF
Natural history of renal angiomyolipoma favours surveillance as an initial approach
Jake Morris
VIEW PDF
Post-nephrectomy upstaging of cT1a to pT3a renal tumor : is renal tumor biopsy a predisposing factor?
Charles Asselin
VIEW PDF
     

State-of-the-Art Lecture 10

   
How long term outcomes have changed our approach in the management of patients with spina bifida
Mark Cain
VIEW PDF
     

Educational Forum 5

   
Optimizing office management of common pediatric problems
Sumit Dave (PDF), Mark Cain (PDF) and Katherine Moore (PDF)
VIEW  
     

State-of-the-Art Lecture 11

   
BPH in the elderly, beyond alpha-blockers and 5-ARI
Steven Kaplan
VIEW PDF
     

Educational Forum 6

   
Old, anticoagulated and can't pee - Challenging BPH cases
Dean Elterman, Steven Kaplan and Mitchell Humphreys
VIEW PDF
     

State-of-the-Art Lecture 12

   
Bladder preservation for muscle invasive disease
Nicholas James
VIEW PDF
     

Educational Forum 7

   
Multidisciplinary genitourinary tumor board
Nicholas James, Christopher French, Girish Kulkarni and Michael Leveridge
VIEW PDF
     

State-of-the-Art Lecture 13

   
Communicating Science
Joe Schwarcz
VIEW PDF